“High-quality research is a matter of national interest. We need to simplify the procedures, integrate institutions into a coherent system, and bridge the gap between research and global innovations.” Six research institutions have made recommendations for the state authorities on research funding and commercialisation in Poland.

In the second episode of the #NCNGeneration series, Prof. Michał Tomza explains how ultracold molecules and ‘perfect vacuum’ help seek answers to one of the greatest questions in physics: why the universe contains more matter than antimatter.

Researchers from Poland, in cooperation with partners from Croatia and Slovenia, will investigate how the HPV virus affects protein trafficking in cells, whilst a Polish research team, in cooperation with partners from Germany, will conduct comparative research on winged altarpieces.

Four research teams involving scientists from Poland have been awarded NCN funding to carry out projects in the field of materials science and materials engineering. The call was organised by the international M-ERA.NET network.  

Pre-announcement of the long-awaited fifth call for two interdisciplinary Dioscuri Centres of Scientific Excellence for outstanding researchers from around the world up to 15 years after their PhD.

In multiple sclerosis, the immune system destroys the nerve sheaths. Aleksandra Rutkowska studies how these sheaths can be rebuilt. She is the first guest in the #PokolenieNCN series marking the 15th anniversary of NCN.

We have just concluded MAESTRO 17 for advanced researchers and SONATA BIS 15 for researchers aiming to form new research teams. 77 projects will be awarded funding of over PLN 250,000,000.

As of the March calls, the proposal form will include a new section on retracted articles. This will provide expert-reviewers with a more comprehensive overview of the publication track record of grant applicants.

Owing to Weave-UNISONO funding, researchers from the Maria Skłodowska-Curie National Research Institute of Oncology together with their German partners will study proteins driving prostate cancer progression.